OncoPrecision

Please join us in congratulating Dr. Constanza Marin on her promotion to Staff Scientist 👩‍🔬🥳🧡

📢 Oral Presentation at #ASH25 We are pleased to share that data from ONC001, our first-in-class CD64-targeting ADC, will be presented by our Co-Founder & Chief Scientific Officer, Dr. Gastón Soria, at the 67th ASH Annual Meeting and Exposition. 🔗: prnewswire.com/news-releases/…

October is hashtag#BreastCancerAwarenessMonth — a reminder of courage, resilience, and the power of science to bring hope 🎀🎀 This month, we’re shining a light on the importance of regular screening, early detection, and continued innovation in the search for new treatments.

Blood cancers affect over 1.2 million people worldwide each year. This #BloodCancerAwarenessMonth, we are reminded of our commitment to raise awareness, support those impacted, and continue to push the boundaries of science so that every patient has a better tomorrow 🩸🧡

OncoPrecision is heading to #BIO2025! We look forward to engaging with partners, industry leaders, and innovators to exchange ideas, explore strategic collaborations, and advance patient-centric drug discovery efforts for novel cancer therapies.

Please join us in congratulating our recently promoted Onconauts! 🎉🧡

On this hashtag#WorldCancerDay we stand united with patients, their families, and all lives that are touched by cancer, as we strive to advance much-needed transformative therapies 🧡

Happy Holidays from the OncoPrecision Team!

Our CEO, @TarekAliZaki, will be participating in a panel discussion on Leveraging the Global Landscape: New Pathways and Geographies in Drug Development on January 15th hosted by @SOSV's @indbio and LOTTE Ventures U.S. lu.ma/ew7dbw2n

Some of this year’s #ASH24 highlights pictured: catching up with our dear Advisors (Dr. @DrGwenNichols, Chief Medical Officer of @LLSusa at their stand and Dr. Jorge Solimano, VP and Head of Hematology of CEMIC over lunch), our annual picture with the ASH sign, and a bit of fun.

That’s a wrap! #ASH24

This weekend, we’re presenting preclinical data from our #CMML & #AML programs at #ASH24 in San Diego. We’re proud to collaborate with experts from @MayoClinic, @MDAndersonNews, @DiscLS, and @OncoPrecision1. Read about our accepted abstracts: bit.ly/3OC7tUS

We’re thrilled to welcome Dr. Stefan Oschmann to our Advisory Board. Dr. Oschmann served as Chairman & CEO of Merck KGaA from 2016 to 2021, successfully leading the company through a period of transformation and growth. linkedin.com/feed/update/ur…

Last Thursday, our Team participated in @LLSusa Light the Night event in Manhattan's South Street Seaport. It was a powerful reminder of the importance of our work as we walked alongside an inspiring community of patients, survivors, and their loved ones 🧡🏮

Our Team wore pink for the #InternationalDayAgainstBreastCancer to raise awareness about breast cancer and promote early detection, diagnosis, and treatment 🩷🎀

Happy birthday to us 🎂4️⃣🧡 Over the past weekend, we celebrated our 4th Birthday by reflecting on our achievements during these first 4 years in our story and on what we hope to accomplish in the years ahead.

October is #BreastCancerAwarenessMonth 🎀🎀 linkedin.com/feed/update/ur…

We just wrapped up our Q4 Goal-Setting meeting at @OncoPrecision1. At the end of every quarter, each Team shares how they performed and what the key objectives for the coming quarter are. Q4 2024 is Q17 in the life of our company. Feeling humbled and tremendously optimistic 🧡🚀

We’re thrilled to have been awarded a Golden Ticket, which will cover a year’s rent for one of our Wet Lab Scientists at our New York HQ. Thank you @BioLabsNY and @NYCEDC for your support 🧡🏆🗽

September is #BloodCancerAwarenessMonth 🩸🩸 linkedin.com/feed/update/ur…